Information on CVID22
Basic details
Name: Immunodeficiency, common variable, 22 | Acronym: CVID22
Alt. names: ITPKB haploinsufficiency
Gene: ITPKB | MOI: Autosomal dominant | Mechanism of action: Haploinsufficiency
No. of cases in DB: 0 | First reported in: 2016
Last updated on: 2023-07-13 13:38:11 by Andrés Caballero-Oteyza
OMIM:
Orphanet: -
MONDO: -
DOID: -
ClinGen:
Description
Only 1 case has been described in the literature with CVID and a chromosomic microdeletion (1q42.1-q42.3) including the gene ITPKB in one allele, and a synonymous variant on the second allele, which was presumed to possibly alter splicing because ITPKB expression was markedly reduced (PMID:26900472). The patient was a 26yo Caucasian man with recurrent S. aureus skin infections requiring multiple courses of antibiotics and incision and drainage for several deep skin abscesses. He also had a history of recurrent childhood ear infections, allergic rhinitis, eczema, schizophrenia, dystonia, seizure disorder and developmental delay. Labs were notable for reduced CD8+ T cells, CD19+ B cells, and NK cells along with poor lymphoproliferative responses and low IgG levels.
Management
Description of management option has not been reviewed yet.
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
0 reported cases added to GenIA
SubjectID | Sex | Fam.ID | AD | AFM | Validity | Country | Population | Reference & Pub.code |
---|
AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).
Summary of clinical findings
[Considering only Definitive and Possible cases]
Rank | Clinical term | Present | Absent | Unreported |
---|
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
Summary of treatment outcomes
[Considering only Definitive and Possible cases]
Treatment ⓘ | Responses & clinical indications |
---|
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.